DK1809767T3 - Fremgangsmåde og sammensætning til forudsigelse reaktionen på warfarin - Google Patents

Fremgangsmåde og sammensætning til forudsigelse reaktionen på warfarin

Info

Publication number
DK1809767T3
DK1809767T3 DK05804256.5T DK05804256T DK1809767T3 DK 1809767 T3 DK1809767 T3 DK 1809767T3 DK 05804256 T DK05804256 T DK 05804256T DK 1809767 T3 DK1809767 T3 DK 1809767T3
Authority
DK
Denmark
Prior art keywords
predicting
warfarin
reaction
composition
compositions
Prior art date
Application number
DK05804256.5T
Other languages
English (en)
Inventor
Mark J Rieder
Allan Rettie
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36181207&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1809767(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Priority claimed from PCT/US2005/037058 external-priority patent/WO2006044686A2/en
Application granted granted Critical
Publication of DK1809767T3 publication Critical patent/DK1809767T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Stringed Musical Instruments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK05804256.5T 2004-10-18 2005-10-17 Fremgangsmåde og sammensætning til forudsigelse reaktionen på warfarin DK1809767T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/967,879 US7445896B2 (en) 2004-10-18 2004-10-18 Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
US11/141,288 US20060084081A1 (en) 2004-10-18 2005-05-31 Methods and compositions for predicting drug responses
PCT/US2005/037058 WO2006044686A2 (en) 2004-10-18 2005-10-17 Methods and compositions for predicting drug responses

Publications (1)

Publication Number Publication Date
DK1809767T3 true DK1809767T3 (da) 2011-12-12

Family

ID=36181207

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05804256.5T DK1809767T3 (da) 2004-10-18 2005-10-17 Fremgangsmåde og sammensætning til forudsigelse reaktionen på warfarin

Country Status (5)

Country Link
US (8) US7445896B2 (da)
AT (1) ATE523601T1 (da)
DK (1) DK1809767T3 (da)
ES (1) ES2373044T3 (da)
IL (1) IL182519A0 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004025157D1 (de) * 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
WO2006012902A2 (en) * 2004-08-02 2006-02-09 Novozymes A/S Creation of diversity in polypeptides
ES2347167T3 (es) * 2004-12-21 2010-10-26 Academia Sinica Variantes geneticas de vkorc1 que predicen la sensibilidad a warfarina.
CA2601574C (en) 2005-03-15 2014-12-02 University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin k-dependent proteins
EP1987146A4 (en) * 2006-01-27 2009-08-19 Paragondx Llc METHOD FOR GENERATING REFERENCE TESTS FOR PHARMACOGENOMIC TESTING
WO2007110869A2 (en) 2006-03-28 2007-10-04 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits for determining predisposition to warfarin resistance
US8380539B2 (en) * 2006-05-09 2013-02-19 University Of Louisville Research Foundation, Inc. Personalized medicine management software
US20070298426A1 (en) * 2006-06-02 2007-12-27 Academia Sinica Warfarin dosage prediction
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US20100137426A1 (en) * 2008-05-01 2010-06-03 Paragon Method for generating reference controls for pharmacogenomic testing
WO2010048020A1 (en) * 2008-10-20 2010-04-29 Epitome Pharmaceuticals Limited Methods and systems for improved pharmaceutical intervention in coagulation control
US9631002B2 (en) 2010-12-21 2017-04-25 The University Of North Carolina At Chapel Hill Methods and compositions for producing active vitamin K-dependent proteins
US9417210B2 (en) 2011-09-30 2016-08-16 Pandora Genomics, LLC System, apparatus and method for evaluating samples or analytes using a point-of-care device
CN108570498B (zh) * 2018-05-25 2021-11-23 山东维真生物科技有限公司 用于检测人类cyp2c9和vkorc1基因多态性的引物探针组合物、试剂盒及应用
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4998617A (en) * 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US5605798A (en) * 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
DE69433811T2 (de) * 1993-01-07 2005-06-23 Sequenom, Inc., San Diego Dns - sequenzierung durch massenspektronomie
US5593826A (en) * 1993-03-22 1997-01-14 Perkin-Elmer Corporation, Applied Biosystems, Inc. Enzymatic ligation of 3'amino-substituted oligonucleotides
WO1995034679A2 (en) 1994-06-16 1995-12-21 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Defects in drug metabolism
GB9415492D0 (en) * 1994-08-01 1994-09-21 Celltech Ltd Biological products
US6379670B1 (en) * 1994-11-18 2002-04-30 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
DE602004025157D1 (de) 2003-09-23 2010-03-04 Univ North Carolina Zellen, die Vitamin-K-Reduktase und Vitamin-K-abhängiges Protein coexprimieren und deren Anwendung zur Verbesserung der Produktivität von diesem Vitamin-K-abhängigen Protein
DE602004026897D1 (de) 2003-10-14 2010-06-10 Baxter Healthcare Sa Vkorc1 (vitamin k epoxide recycling polypeptide), ein therapeutisches ziel für coumarin und deren derivate
WO2006044686A2 (en) 2004-10-18 2006-04-27 University Of Washington Methods and compositions for predicting drug responses
ES2347167T3 (es) * 2004-12-21 2010-10-26 Academia Sinica Variantes geneticas de vkorc1 que predicen la sensibilidad a warfarina.

Also Published As

Publication number Publication date
ATE523601T1 (de) 2011-09-15
US8153366B2 (en) 2012-04-10
US20080050732A1 (en) 2008-02-28
US20110251272A1 (en) 2011-10-13
US20080057500A1 (en) 2008-03-06
US20080318219A1 (en) 2008-12-25
US20060084081A1 (en) 2006-04-20
US7888016B2 (en) 2011-02-15
US7829282B2 (en) 2010-11-09
US7445896B2 (en) 2008-11-04
US9074257B2 (en) 2015-07-07
US20060084070A1 (en) 2006-04-20
US20140148505A1 (en) 2014-05-29
HK1105437A1 (en) 2008-02-15
US8614060B2 (en) 2013-12-24
IL182519A0 (en) 2007-09-20
ES2373044T3 (es) 2012-01-30
US20080050733A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
IL182519A0 (en) Methods and compositions for predicting drug responses
WO2007146819A3 (en) Methods for identifying and using snp panels
WO2004003220A3 (en) Methods and composition for analyzing compromised samples using snps
WO2008069906A3 (en) Digital expression of gene analysis
DE602006017365D1 (de) Zusammensetzungen für die identifizierung von adenoviren
WO2004101806A3 (en) Allele-specific expression patterns
TW200637918A (en) Genetic variants predicting warfarin sensitivity
NO20071918L (no) Fremgangsmate for simulering av de korrosive virkningene av raffineriramaterialer pa raffineri metallurgi.
Hirvensalo et al. Enantiospecific pharmacogenomics of fluvastatin
WO2005082110A3 (en) Haplotype markers for diagnosing susceptibility to immunological conditions
Pietarinen et al. High Frequency of CYP 2D6 Ultrarapid Metabolizer Genotype in the Finnish Population
WO2006057918A3 (en) Detection of nucleic acid variation by cleavage-amplification method
WO2009032316A3 (en) Genetic polymorphisms associated with rheumatoid arhritis, methods of detection and uses thereof
Fan et al. Detecting a hierarchical genetic population structure via Multi-InDel markers on the X chromosome
DK2061910T3 (da) Fremgangsmåde til prognose
WO2008121899A3 (en) Method of predicting a predisposition to qt prolongation
ATE386823T1 (de) Marker-unterstützte rinderauswahl für verbesserte milchzusammensetzung
Lei et al. Effects of PON1 gene promoter DNA methylation and genetic variations on the clinical outcomes of dual antiplatelet therapy for patients undergoing percutaneous coronary intervention
DE112005001317A5 (de) Polymorphismen im NOD2/Card15 Gen
Sim et al. High‐throughput STR analysis for DNA database using direct PCR
WO2006044686A3 (en) Methods and compositions for predicting drug responses
WO2006025983A3 (en) Labeled substrate conjugates for identifying enzyme inhibitors
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2008048902A8 (en) Methods of using single nucleotide polymorphisms in the il23r gene to predict or diagnose inflammatory bowel disease
WO2007050794A3 (en) The il-1 gene cluster and associated inflammatory polymorphisms and haplotypes